Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
148
-
Total 13F shares, excl. options
-
18,521,451
-
Shares change
-
-2,123,394
-
Total reported value, excl. options
-
$1,074,614,778
-
Value change
-
-$285,250,387
-
Put/Call ratio
-
83%
-
Number of buys
-
92
-
Number of sells
-
-78
-
Price
-
$58.04
Significant Holders of INTERCEPT PHARMACEUTICALS IN - COM (ICPT) as of Q3 2017
222 filings reported holding ICPT - INTERCEPT PHARMACEUTICALS IN - COM as of Q3 2017.
INTERCEPT PHARMACEUTICALS IN - COM (ICPT) has 148 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18,521,451 shares
.
Largest 10 shareholders include FMR LLC (3,764,290 shares), Capital World Investors (1,853,959 shares), AMERIPRISE FINANCIAL INC (1,450,512 shares), VANGUARD GROUP INC (1,384,056 shares), BlackRock Inc. (1,160,750 shares), STATE STREET CORP (900,003 shares), JPMORGAN CHASE & CO (891,573 shares), Senvest Management, LLC (583,790 shares), BB BIOTECH AG (485,719 shares), and ORBIMED ADVISORS LLC (386,380 shares).
This table shows the top 148 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.